ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
stotes
|
34 |
11K |
11 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
34
|
11K
|
11
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
stotes
|
34 |
11K |
23 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
34
|
11K
|
23
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Product Development Milestones & Grant Funding Achieved
|
|
stotes
|
26 |
8.9K |
16 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
26
|
8.9K
|
16
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Extends Commercial Development Agreement
|
|
stotes
|
39 |
9.4K |
9 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
39
|
9.4K
|
9
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Extends Commercial Development Agreement
|
|
stotes
|
39 |
9.4K |
8 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
39
|
9.4K
|
8
|
|
Charts
|
RC1 |
Re:
RC1 Technical Analysis Discussion
|
|
stotes
|
18 |
10K |
2 |
22/03/23 |
22/03/23 |
Charts
|
18
|
10K
|
2
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appointment of New CFO & Company Secretary
|
|
stotes
|
28 |
8.9K |
6 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
28
|
8.9K
|
6
|
|
Charts
|
RC1 |
Re:
RC1 Technical Analysis Discussion
|
|
stotes
|
18 |
10K |
5 |
17/03/23 |
17/03/23 |
Charts
|
18
|
10K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Allowance of United States Patent
|
|
stotes
|
3 |
1.2K |
3 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Allowance of United States Patent
|
|
stotes
|
3 |
1.2K |
10 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
3
|
1.2K
|
10
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene and STK Agree Binding Terms on Global Collaboration
|
|
stotes
|
43 |
15K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
43
|
15K
|
1
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene and STK Agree Binding Terms on Global Collaboration
|
|
stotes
|
43 |
15K |
5 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
43
|
15K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene and STK Agree Binding Terms on Global Collaboration
|
|
stotes
|
43 |
15K |
10 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
43
|
15K
|
10
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Receives R&D Tax Incentive
|
|
stotes
|
1 |
642 |
7 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
1
|
642
|
7
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene and STK Agree Binding Terms on Global Collaboration
|
|
stotes
|
43 |
15K |
15 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
43
|
15K
|
15
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Trading Halt
|
|
stotes
|
21 |
5.2K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
21
|
5.2K
|
1
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Trading Halt
|
|
stotes
|
21 |
5.2K |
4 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
21
|
5.2K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Trading Halt
|
|
stotes
|
21 |
5.2K |
17 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
21
|
5.2K
|
17
|
|
ASX - By Stock
|
HMD |
Re:
What are the chances of this company?
|
|
stotes
|
107 |
27K |
3 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
107
|
27K
|
3
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Manufacturing Update Webinar
|
|
stotes
|
19 |
5.9K |
6 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
19
|
5.9K
|
6
|
|
ASX - By Stock
|
RNE |
Re:
Ann: ReNu Energy Completes Capital Raise
|
|
stotes
|
57 |
16K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
57
|
16K
|
1
|
|
ASX - By Stock
|
RNE |
Re:
Ann: ReNu Energy Completes Capital Raise
|
|
stotes
|
57 |
16K |
0 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
57
|
16K
|
0
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.5M |
15 |
13/12/22 |
13/12/22 |
Charts
|
2.8K
|
1.5M
|
15
|
|
ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
stotes
|
102 |
35K |
3 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
102
|
35K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: $8.8m In Non-Dilutive Funding To Be Received This Quarter
|
|
stotes
|
13 |
4.3K |
1 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
13
|
4.3K
|
1
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Submits Application for Plant Breeders Rights
|
|
stotes
|
4 |
1.8K |
6 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
4
|
1.8K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: $8.8m In Non-Dilutive Funding To Be Received This Quarter
|
|
stotes
|
13 |
4.3K |
12 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
13
|
4.3K
|
12
|
|
ASX - By Stock
|
EMV |
Re:
Ann: $8.8m In Non-Dilutive Funding To Be Received This Quarter
|
|
stotes
|
13 |
4.3K |
16 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
13
|
4.3K
|
16
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Commences Clinical Trial
|
|
stotes
|
33 |
14K |
6 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
33
|
14K
|
6
|
|
ASX - By Stock
|
RNE |
Re:
Ann: ReNu Energy Completes Capital Raise
|
|
stotes
|
57 |
16K |
1 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
57
|
16K
|
1
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene 2022 AGM - Chairman's Address
|
|
stotes
|
6 |
2.1K |
3 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
6
|
2.1K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Random AGM notes & quotes
|
|
stotes
|
27 |
8.3K |
8 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
27
|
8.3K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Random AGM notes & quotes
|
|
stotes
|
27 |
8.3K |
15 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
27
|
8.3K
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Backed By NSW Medical Devices Fund With $2.5m Grant
|
|
stotes
|
45 |
15K |
15 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
45
|
15K
|
15
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.5K |
1.2M |
11 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
2.5K
|
1.2M
|
11
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.5K |
1.2M |
2 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.5K
|
1.2M
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
stotes
|
10 |
2.8K |
8 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
10
|
2.8K
|
8
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Significant Developments in Molecule Manufacturing - Update
|
|
stotes
|
3 |
1.8K |
8 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
3
|
1.8K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.5K |
1.2M |
20 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
2.5K
|
1.2M
|
20
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.5K |
1.2M |
6 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
2.5K
|
1.2M
|
6
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Update on Development Program with BASF
|
|
stotes
|
117 |
32K |
8 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
117
|
32K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Secures Strategic Agreement With Keysight
|
|
stotes
|
41 |
12K |
6 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
41
|
12K
|
6
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.5M |
29 |
28/04/22 |
28/04/22 |
Charts
|
2.8K
|
1.5M
|
29
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.5M |
10 |
27/04/22 |
27/04/22 |
Charts
|
2.8K
|
1.5M
|
10
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4C - 31 March 2022
|
|
stotes
|
50 |
11K |
21 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
50
|
11K
|
21
|
|
ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
stotes
|
102 |
35K |
2 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
102
|
35K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.5K |
1.2M |
17 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
2.5K
|
1.2M
|
17
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Bio-Gene Executes Commercial Development Agreement
|
|
stotes
|
70 |
19K |
10 |
17/04/22 |
17/04/22 |
ASX - By Stock
|
70
|
19K
|
10
|
|
ASX - By Stock
|
TPD |
Re:
Ann: TMK: Thick Gassy Coal Seam Intersected in Mongolia
|
|
stotes
|
60 |
26K |
1 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
60
|
26K
|
1
|
|
ASX - By Stock
|
TMK |
Re:
Ann: Thick Gassy Coal Seam Intersected in Mongolia
|
|
stotes
|
60 |
21K |
10 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
60
|
21K
|
10
|
|